Developmental and liver-specific expression directed by the serum amyloid P component promoter in transgenic mice.
Transgenic mice were produced by microinjection of a human serum amyloid P component (hSAP) gene or a fusion gene (SS) comprising the promoter for hSAP (nucleotides -600 to -14 from the start codon) and the coding region of the hepatitis B virus surface antigen (HBsAg). In adult mice, both transgenes were expressed only in the liver, and thus the pattern of expression resembled that of the endogenous mouse SAP gene. Both hSAP mRNA and HBsAg were first detected in liver on the second postnatal day. The level of these products increased rapidly and reached the maximum within the first week. These results suggest that the hSAP gene contains a short, cis-acting, developmental, and liver-specific regulatory sequence at the 5' or the 3' end and that this sequence can target expression of the foreign gene.
Zhao
X
X
Institute for Medical Genetics, Kumamoto University Medical School.
Araki
K
K
Miyazaki
J
J
Yamamura
K
K
D000818:Animals; D003001:Cloning, Molecular; D006128:Growth / Q000235:genetics; D006514:Hepatitis B Surface Antigens / Q000235:genetics; D006801:Humans; D008099:Liver / Q000378:metabolism; D051379:Mice; D008822:Mice, Transgenic; D011401:Promoter Regions, Genetic; D000683:Serum Amyloid P-Component / Q000235:genetics*
D006514:Hepatitis B Surface Antigens; D000683:Serum Amyloid P-Component